These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 56315)

  • 1. The lupus erythematosus cell phenomenon: mechanisms and significance.
    Zweiman B; Hebert J
    Int J Dermatol; 1976 Mar; 15(2):121-4. PubMed ID: 56315
    [No Abstract]   [Full Text] [Related]  

  • 2. ["False positive" LE cell phenomenon].
    Bartusch M; Krug K
    Z Rheumaforsch; 1969; 28(7):298-305. PubMed ID: 4186550
    [No Abstract]   [Full Text] [Related]  

  • 3. The immunofluorescent tumor imprint technique. IV. The significance of "thready" nuclear immunofluorescence.
    Burnham TK; Neblett TR; Fine G; Bank P
    Arch Dermatol; 1969 May; 99(5):611-6. PubMed ID: 4889089
    [No Abstract]   [Full Text] [Related]  

  • 4. [The significance of immunologic tests in the diagnosis and differential diagnosis of systemic lupus erythematosus and rheumatoid arthritis].
    Guceva B; Grlickov M; Marina N; Calovski J; Cakalaroska D; Pusevski A
    Reumatizam; 1980; 27(1):1-4. PubMed ID: 6156480
    [No Abstract]   [Full Text] [Related]  

  • 5. Antinucleolar antibodies. Their frequency and diagnostic association.
    Ritchie RF
    N Engl J Med; 1970 May; 282(21):1174-8. PubMed ID: 4909324
    [No Abstract]   [Full Text] [Related]  

  • 6. [The diagnostic and differential diagnostic value of anti-DNA antibodies in collagen diseases, especially in disseminated lupus erythematosus].
    Małdyk H; Chwalińska-Sodowska H; Grabowska A; Swierczynska Z; Rdułtowska B
    Verh Dtsch Ges Rheumatol; 1978; 5():107-9. PubMed ID: 309225
    [No Abstract]   [Full Text] [Related]  

  • 7. [Possibilities of differentiation of antinuclear antibodies].
    Müller W; Rosenthal M; Stojan B
    Z Gesamte Inn Med; 1975 Oct; 30(20):665-71. PubMed ID: 766433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunologic methods in the differential diagnosis of collagen diseases].
    Kalden JR
    Med Welt; 1975 Dec; 26(50):2242-7. PubMed ID: 765672
    [No Abstract]   [Full Text] [Related]  

  • 9. Antinuclear antibody and rheumatoid factor estimations in the diagnosis of rheumatic diseases in northern India.
    Malaviya AN; Banerjee S; Misra RN; Kaul R; Bhuyan UN
    Asian Pac J Allergy Immunol; 1984 Dec; 2(2):232-6. PubMed ID: 6335834
    [No Abstract]   [Full Text] [Related]  

  • 10. ANTINUCLEAR ANTIBODIES IN FAMILIES OF PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS.
    POLLAK VE
    N Engl J Med; 1964 Jul; 271():165-71. PubMed ID: 14158353
    [No Abstract]   [Full Text] [Related]  

  • 11. [Immunofluorescent studies in some autoimmune syndromes. I. Lupus erythematosus].
    Chorzelski T; Blaszczyk M
    Przegl Dermatol; 1971; 58(4):485-8. PubMed ID: 4938588
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparative evaluation of antinuclear factor tests in rheumatic disorders.
    Willkens RF; Decker JL; Wilske KR
    Med Clin North Am; 1968 May; 52(3):559-65. PubMed ID: 4385202
    [No Abstract]   [Full Text] [Related]  

  • 13. Diagnosis of systemic lupus erythematosus. Importance of antinuclear antibody titers and peripheral staining patterns.
    Nisengard RJ; Jablonska S; Chorzelski TP; Blaszcyk M; Jarret C; Beutner EH
    Arch Dermatol; 1975 Oct; 111(10):1298-300. PubMed ID: 54050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The immunofluorescent "band" test in mixed connective tissue disease.
    Levitin PM; Weary PE; Giuliano VJ
    Ann Intern Med; 1975 Jul; 83(1):53-5. PubMed ID: 1096702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic aspects of lupus erythematosus cells and antinuclear factors in disease states.
    Barnett EV
    Mayo Clin Proc; 1969 Sep; 44(9):645-8. PubMed ID: 4186061
    [No Abstract]   [Full Text] [Related]  

  • 16. Significance of antinuclear factor in the connective tissue diseases.
    Rowell NR; Beck JS
    Ann Rheum Dis; 1970 Mar; 29(2):201-2. PubMed ID: 4393304
    [No Abstract]   [Full Text] [Related]  

  • 17. Historical perspectives of collagen diseases.
    Miescher PA; Tucci A
    Clin Dermatol; 1992; 10(4):393-7. PubMed ID: 1284658
    [No Abstract]   [Full Text] [Related]  

  • 18. The identification of lupus erythematosus cells. A comparison of supravital fluorochromation with a standard Wright's stain method.
    Sodeman TM; Isaac PC; Stanek C; Nishiyama RH
    Am J Clin Pathol; 1975 Feb; 63(2):240-4. PubMed ID: 46694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significance of nuclear immunofluorescent patterns.
    Dorsch CA; Gibbs CB; Stevens MB; Shulman LE
    Ann Rheum Dis; 1969 May; 28(3):313-9. PubMed ID: 4890805
    [No Abstract]   [Full Text] [Related]  

  • 20. Diseases in which antinuclear antibody and-or rheumatoid factor are usually present. (Rheumatoid arthritis, systemic lupus erythematosus, systemic sclerosis).
    Sheon RP; Kirsner AB
    Med Times; 1973 Feb; 101(2):97-113. PubMed ID: 4539866
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.